Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Ed Rayner to its Board of Directors as a Non-Executive Director.
China’s NMPA approves Antengene’s XPOVIO for DLBCL treatment
One of the most prevalent subtypes of adult non-Hodgkin lymphoma is diffuse large B-cell lymphoma. Credit: Nemes Laszlo/ Shutterstock. China’s National Medical Products Administration (NMPA)